Status:
RECRUITING
Outcome and Improvement of Different Treatment in Arteriosclerosis Obliterans
Lead Sponsor:
First Affiliated Hospital, Sun Yat-Sen University
Conditions:
Arteriosclerosis Obliterans
Eligibility:
All Genders
18+ years
Brief Summary
This study is a prospective, single-center, observational study. In this study, we aim to evaluate the clinical outcome and cost-effectiveness of different treatments of lower extremity arterial occlu...
Detailed Description
Arteriosclerosis obliterans (ASO) is a kind of lower extremity arterial disease which occurs frequently in middle-aged and elderly people. The incidence of ASO increases with age. In patients with ASO...
Eligibility Criteria
Inclusion
- Age 18 years or older, gender is not limited.
- Patients diagnosed with arteriosclerosis obliterans.
- Rutherford stages 2-6.
- When there are multiple stenosis lesions, the treatment of the most severe lesion is included.
- Patients with at least one arterial occlusion ( iliac, femoral, popliteal, anterior tibial, posterior tibial, and/or peroneal artery) of the lower extremity were included.
Exclusion
- Malignant tumor
- Alzheimer's disease
- Blood disease or bleeding tendency
- Heart Failure Grade III \~ IV
- Pregnancy or lactation
- An above-knee-below-knee amputation has been performed
- Unable to accept therapeutic function tests
- Life expectancy is less than six months
- Combined with other diseases affecting walking
- Cardiovascular and cerebrovascular events occurred within 3 months, including non-fatal myocardial infarction, unstable angina, stable angina, non-fatal ischemic stroke and hemorrhagic stroke
- Patients with significant abnormal liver and renal function that the investigators judged to be clinically significant
Key Trial Info
Start Date :
July 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2029
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06485622
Start Date
July 1 2024
End Date
July 1 2029
Last Update
August 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China, 510030